Chrysiis Michaloglou

机构：AstraZeneca (United Kingdom), AstraZeneca (Singapore)

发表论文 27 篇 · 总被引 7105 次 · h-index 9

代表论文

• Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network (2008 · Cell · 被引 2067)
• The essence of senescence: Figure 1. (2010 · Genes & Development · 被引 2022)
• Abrogation of BRAF V600E -induced senescence by PI3K pathway activation contributes to melanomagenesis (2012 · Genes & Development · 被引 257)
• Combined Inhibition of mTOR and CDK4/6 Is Required for Optimal Blockade of E2F Function and Long-term Growth Inhibition in Estrogen Receptor–positive Breast Cancer (2018 · Molecular Cancer Therapeutics · 被引 193)
• The Tyrosine Phosphatase PTPN14 Is a Negative Regulator of YAP Activity (2013 · PLoS ONE · 被引 94)
• PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors (2022 · OncoImmunology · 被引 53)